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Conjugated bile salt hydrolase (BSH) catalyses the hydrolysis of the
amide bond that conjugates bile acids to glycine and to taurine. The
BSH enzyme from Bi®dobacterium longum was overexpressed in
Escherichia coli BL21(DE3), puri®ed and crystallized. Crystallization
conditions were screened using the hanging-drop vapour-diffusion
method. Crystal growth, with two distinct morphologies, was optimal
in experiments carried out at 303 K. The crystals belong to the
hexagonal system, space group P622 with unit-cell parameters
a = b = 124.86, c = 219.03 AÊ , and the trigonal space group P321,
with unit-cell parameters a = b = 125.24, c = 117.03 AÊ . The crystals
diffracted X-rays to 2.5 AÊ spacing. Structure determination using the
multiple isomorphous replacement method is in progress.
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1. Introduction
Bile acids normally exist in a conjugated form
bonded to glycine or taurine by a carboxyl side
chain and effect the digestion and absorption
of lipids. Circulation of bile acids occurs in the
bowel, with most of the bile acids discharged
into the intestine being absorbed through the
ileum to be recovered by the liver (Russell,
2003). Stagnation of this circulation leads to
diseases of the hepatic/bile duct and digestive
tract. In recent years, increased attention has
been given to the possibility of using bile-salt
conjugation carried out by lactic acid bacteria
to lower serum cholesterol levels in hyper-
cholestraemic humans or to prevent hyper-
cholesterolaemia in individuals with normal
cholesterol levels (Drasar et al., 1966; Larsen et
al., 2000). Bile acids are also the natural ligands
for the farnesoid-X nuclear receptor. There-
fore, bile acids may be important regulators of
gene expression in the liver and intestines
(Torchia et al., 2001).
The hydrolysis of conjugated bile salts is a
common microbe-assisted biotransformation.
As Bi®dobacteria are one of the main bacterial
groups in the gut, they play an important role
in the transformation of bile salts in the
intestine (Grill et al., 1995). Members of the
genus Bi®dobacterium have the ability to
deconjugate bile salts; six different salts are
deconjugated by all strains of the organism.
Bile salt hydrolase (BSH; cholylglycine
hydrolase; EC 3.5.1.24) catalyses the hydrolysis
of glycine- and taurine-conjugated bile salts
into the corresponding amino-acid residues
and the deconjugated bile salts. On the basis of
sequence similarity with BSH enzymes of other
bacteria, as well as with penicillin V acylase
(PVA) from Bacillus sphaericus, the crystal
structure of which has been elucidated (Suresh
et al., 1999), BSH from B. longum can be
classi®ed as belonging to the N-terminal
nucleophile hydrolase family (Brannigan et al.,
1995), with Cys as the N-terminal catalytic
residue. The majority of the amino acids
identi®ed in the catalytic centre and oxyanion
hole of PVA are conserved in the sequence of
BSH (Tanaka et al., 2000). It will be interesting
to study the mechanism of action of BSH and
its speci®city in comparison with PVA via
structural analysis. With this in mind, we have
crystallized BSH from B. longum and carried
out preliminary crystallographic analysis.
2. Materials and methods
2.1. Construction of the overexpression
plasmid pET26/bsh
The gene encoding B. longum BSH was
ampli®ed from the plasmid pBH1351 (Tanaka
et al., 2000) by PCR using the oligonucleotide
primers 50-GGAGTCATTAATGTGCACTG-
GTGTCCGTTTC-30 and 50-GGAAGAAT
TCATCGGGCGACGCTGATGAG-30, which
incorporate the restriction endonuclease sites
AseI and EcoRI (highlighted in bold), respec-
tively. Digested PCR product was cloned into
the T7 promotor-based pET26b(+) expression
vector (Novagen) digested at NdeI and EcoRI
restriction sites and transformed into the
Escherichia coli BL21(DE3) host strain for
overexpression. The sequence of the coding
region was con®rmed by DNA sequencing.
2.2. Overexpression and purification
20 ml of stationary phase (BL21/pET26/bsh)
culture was inoculated into 2 l of Luria±
Bertani medium containing 35 mg mlÿ1 kana-
mycin. The culture was grown at 310 K to an
electronic reprint
crystallization papers
OD600 value of 0.6, followed by induction
with 1 mM isopropyl -d-1-thiogalacto-
pyranoside (IPTG). The cells were har-
vested by centrifugation after 5 h and the
cell pellet was resuspended in 50 mM
potassium phosphate buffer pH 6.5
containing 10 mM DTT prior to storage at
203 K.
The cell suspension was thawed and lysed
by sonication. Cell debris was removed by
centrifugation at 18 000g for 20 min at
277 K. To remove residual DNA, 1% strep-
tomycin sulfate was added and the suspen-
sion was stirred for 20 min prior to
centrifugation for 10 min at 18 000g and
277 K. The cell extract was subjected to
ammonium sulfate (AS) protein precipita-
tion at 80% saturation, resuspended and
dialysed against potassium phosphate buffer
pH 6.5. The dialysate was treated with 24%
AS and applied to a 200 ml octyl-Sepharose
column (Sigma) equilibrated with the same
concentration of AS in potassium phosphate
buffer pH 6.5 and eluted with a linear
gradient of AS. Fractions were analysed by
SDS±PAGE and those containing BSH were
pooled and dialysed against Tris±HCl buffer
pH 8.0 and applied to a MonoQ column
(Amersham Pharmacia Biotech) equili-
brated with the same buffer and eluted with
a 0±1 M NaCl linear gradient. The enzyme
fractions were pooled and concentrated in a
Centriprep concentrator (Amicon). The
concentrated preparation was buffer-
exchanged into 10 mM potassium phosphate
buffer pH 6.5 containing 10 mM DTT using
PD-10 desalting columns (Amersham Phar-
macia Biotech) and ®nally concentrated to
16 mg mlÿ1 protein before storage at 203 K.
Protein concentration was determined in
accordance with the method of Lowry et al.
(1951), with BSA as a standard.
2.3. Dynamic light scattering
Dynamic light-scattering experiments
were performed on a DynaPro instrument
(Protein Solutions). Measurements were
made at 291 K using the puri®ed protein at
0.1±0.5 mg mlÿ1 in buffer solution con-
taining 10 mM potassium phosphate pH 6.5
and 10 mM DTT.
2.4. Crystallization
The initial screening of crystallization
conditions was carried out by the sparse-
matrix method using Crystal Screen kits
(Hampton Research, USA) and Clear
Strategy Screens I and II. All crystallization
screens were performed at 296 K employing
the hanging-drop vapour-diffusion method
in 24-well Linbro plates (ICN Biomedicals).
Crystallization conditions were re®ned by
variation of precipitant [15±35%(w/v) PEG
400; 30% AS saturation and above], pH
(5.0±8.5), protein concentration (10±
30 mg mlÿ1), additives (ethylene glycol,
glycerol, methanol, ethanol, acetone, -octyl
glucoside, -ME, dioxane, sucrose and
maltose) and temperature (277, 293 and
303 K). In each trial, a hanging drop of 1 ml
protein solution mixed with 1 ml reservoir
solution was equilibrated against a reservoir
of 500 ml precipitant solution.
2.5. Data collection
Preliminary diffraction data were
collected in-house using an R-AXIS IV++
image-plate detector mounted on a Rigaku
RU-2000 rotating-anode X-ray generator
running at 50 kV and 100 mA producing
Cu K ( = 1.5418 AÊ ) radiation. The beam
was focused using Osmic confocal mirrors.
Crystals were immersed in a cryoprotectant
solution consisting of mother liquor supple-
mented with 30% glycerol. The crystals were
mounted in a loop and ¯ash-cooled in a
stream of nitrogen gas cooled to 100 K. All
intensity data were indexed, integrated and
scaled using the HKL programs DENZO
and SCALEPACK (Otwinowski & Minor,
1997). The exposure time was 8 min per
frame, the crystal-to-detector distance was
200 mm and the oscillation range was 0.5.
3. Results and discussion
The preparation of recombinant protein has
provided a reliable supply of pure protein
for crystallization. A ®nal yield of 7.5 mg of
pure protein per litre of cell culture was
obtained. The purity of the protein was
con®rmed using SDS±PAGE, native PAGE
and dynamic light-scattering analysis, the
latter indicating the presence of tetramers in
solution. The SDS±PAGE (12%) analysis
using medium-molecular-weight markers
(Sigma) gave a single band at 36.5 kDa
(Fig. 1), whereas the molecular weight
estimated using gel chromatography with
standard proteins (aprotinin, carbonic
anhydrase, BSA and alcohol dehydrogenase;
Sigma) was 146 kDa, con®rming the homo-
tetrameric form of BSH in solution. The
speci®c activity of the puri®ed enzyme used
for the crystallization was 30 IU mgÿ1 using
glycocholic acid (Sigma) as substrate at pH
6.0 and 315 K.
The sparse-matrix screens (Crystal
Screens I and II from Hampton Research
and Clear Strategy Screens I and II) showed
that the protein crystallized with different
morphologies under a variety of conditions.
Initially, most of these crystals were not
suitable for X-ray measurements owing to
their small size and growth defects. The best
crystals were obtained (i) with 30%(w/v)
PEG 400, 100 mM HEPES pH 7.2 and 0.2 M
MgCl2 (hexagonal form only) and (ii) with
ammonium sulfate (30% saturation), 0.5 M
sodium formate, 0.2 M sucrose and
0.04%(w/v) -octylglucoside at pH 6.7 (both
hexagonal and trigonal forms). Crystals
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Figure 1
SDS±PAGE analysis of puri®ed BSH. Lane M
contains standard medium-range molecular-weight
markers (Sigma). BSH indicates the lane containing
recombinant bile salt hydrolase.
Figure 2
(a) Hexagonal crystal form of BSH from B. longum
grown from conditions using PEG 400 as the
precipitant. (b) Trigonal crystal form of BSH from
B. longum grown from conditions using ammonium
sulfate as the precipitant.
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appeared after 4 d from each of the condi-
tions using 15 mg mlÿ1 protein solution in
10 mM sodium phosphate buffer pH 6.5
containing 10 mM DTT. The crystallization
conditions were optimized for non-ionic
detergent concentration and incubation
temperature to improve the quality of crys-
tals. The crystals grew to approximate
dimensions of 0.4  0.2  0.2 mm in both
forms (Fig. 2).
The best quality crystals, grown at 303 K,
diffracted X-rays to 2.5 AÊ spacing and were
found to belong to space groups P622, with
unit-cell parameters a = b = 87.66,
c = 160.28 AÊ , and P321, with unit-cell para-
meters a = b = 125.24, c = 117.02 AÊ . Detailed
data-collection statistics are given in Table 1.
The values of the Matthews coef®cient VM
(Matthews, 1968), determined assuming
dimers in the asymmetric unit in each case,
were 3.5 and 3.8 AÊ 3 Daÿ1, respectively, for
the hexagonal and trigonal forms. The
corresponding values for solvent content
were 65.1 and 67.5%, respectively. The
possibility of the presence of a tetramer in
the asymmetric unit, although close to the
extreme limit (VM for the hexagonal and
trigonal forms being 1.7 and 1.8 AÊ 3 Daÿ1
with solvent contents of 27 and 32%,
respectively), cannot be ruled out. Despite
sequence homology (30% identity) and
shared tetrameric quaternary structure with
PVA (Suresh et al., 1999), preliminary
attempts at molecular replacement have not
been successful. Attempts to obtain crystals
with heavy-atom derivatives for multiple
isomorphous replacement methods are
under way.
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Table 1
Data-collection and processing statistics.
Values in parentheses correspond to the outer resolution shell.
Hexagonal Trigonal
Detector and wavelength (AÊ ) R-AXIS IV++, 1.5418 R-AXIS IV++, 1.5418
Space group P622 P321
Unit-cell parameters
a = b (AÊ ) 124.86 125.24
c (AÊ ) 219.03 117.03
Resolution range (AÊ ) 20±2.50 (2.54±2.50) 20±2.50 (2.55±2.50)
Total observations 473577 154427
Unique re¯ections 35692 37170
Average I/(I) 21.9 (5.5) 18.8 (3.6)
Rmerge² (%) 9.0 (48.0) 6.0 (39.0)
Completeness (%) 99.7 (100) 99.5 (100)
² Rmerge =
P
hkl
P
i jIihkl ÿ hIhklij=
P
hkl
P
i Iihkl.
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